Shanghai Universal Biotech Co.,Ltd.

¥29.07As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301166Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (21.79%)
Div yield 2.06%
ROE (0.78%)
Biotechnology
Beta (5Y) 1.07
PE TTM —
TSR TTM (7.42%)
Mkt cap ¥2.478B
ROIC (5.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥35
21.65%
60.62%
Hold 10|8|11|4|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.42
0.46
0.43
0.42
16.31%
18.13%
18.37%
9.96%
Revenue¥M
201.2
210.1
217.4
212.2
9.90%
9.90%
12.73%
8.50%
Peers (US$371.5M)
Cap (US$)
PE
374.4M
39.28x
Capital
TTM
5Y
10Y
Leveragex
0.471
—
—
EBIT/Intx
0.215
0.189
0.170
Own earn%
(399.08)
7.07
10.41
Sh yield%
21.38
48.79
47.63
Owners
Insiders/Inst%
12.66
21.05
Short interest%
2.12
SBC / revenue%
5.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
0–4
$1 testx
0.9
Incr. ROIC%
29